Earnings Feed
Sign Up
Home/Filings/4/0001104659-17-069120
4//SEC Filing

HealthCare Ventures IX, L.P. 4

Accession 0001104659-17-069120

CIK 0001509745other
View on SEC.govCompany Profile

Filed

Nov 15, 7:00 PM ET

Accepted

Nov 16, 1:45 PM ET

Size

11.6 KB

Accession

0001104659-17-069120

Insider Transaction Report

Form 4
Period: 2017-11-14
LEAP THERAPEUTICS, INC.LPTX
HealthCare Ventures IX, L.P.
10% Owner
Transactions
  • Purchase

    Warrant (Right to Buy)

    2017-11-14+1,057,769→ 1,057,769 total
    Exercise: $6.08From: 2017-11-14Exp: 2024-11-14→ Common Stock, $0.001 par value per share (1,057,769 underlying)
  • Purchase

    Common Stock

    2017-11-14$6.08/sh+1,057,769$6,436,524→ 3,573,376 total
Healthcare Partners IX, LLC
10% Owner
Transactions
  • Purchase

    Warrant (Right to Buy)

    2017-11-14+1,057,769→ 1,057,769 total
    Exercise: $6.08From: 2017-11-14Exp: 2024-11-14→ Common Stock, $0.001 par value per share (1,057,769 underlying)
  • Purchase

    Common Stock

    2017-11-14$6.08/sh+1,057,769$6,436,524→ 3,573,376 total
Healthcare Partners IX, L.P.
10% Owner
Transactions
  • Purchase

    Warrant (Right to Buy)

    2017-11-14+1,057,769→ 1,057,769 total
    Exercise: $6.08From: 2017-11-14Exp: 2024-11-14→ Common Stock, $0.001 par value per share (1,057,769 underlying)
  • Purchase

    Common Stock

    2017-11-14$6.08/sh+1,057,769$6,436,524→ 3,573,376 total
Footnotes (2)
  • [F1]The shares are owned directly by HealthCare Ventures IX, L.P. Christopher K. Mirabelli, Douglas E. Onsi and Augustine Lawlor (collectively, the "HCVIX Directors") are the Managing Directors of HealthCare Partners IX, LLC ("HCPIX LLC"), which is the General Partner of HealthCare Partners IX, L.P. ("HCPIX"), which is the General Partner of HealthCare Ventures IX, L.P. Each of the HCVIX Directors, HCPIX LLC and HCPIX indirectly beneficially own and share voting and dispositive power with respect to all of the securities owned by HealthCare Ventures IX, L.P. and each disclaims beneficial ownership of these shares except to the extent of his or its proportionate pecuniary interest in these securities.
  • [F2]The reported securities were included with the 1,057,759 shares of common stock purchased by the reporting persons for $6.085 per share. Each such purchased share of common stock was issued with a warrant to purchase one share of common stock.

Documents

1 file

Issuer

LEAP THERAPEUTICS, INC.

CIK 0001509745

→
Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001490245

Filing Metadata

Form type
4
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 1:45 PM ET
Size
11.6 KB
View on SEC.gov